Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease

Background and Aim Acute kidney injury (AKI) commonly occurs in patients with chronic liver disease (CLD). As per the International Club of Ascites, AKI is classified into three stages; stage 1 has recently been divided into subgroups 1A and 1B. We performed a prospective study to validate the assoc...

Full description

Bibliographic Details
Main Authors: Chitta R Khatua, Saroj K Sahu, Rakesh K Barik, Subhasis Pradhan, Subhendu Panigrahi, Debakanta Mishra, Shivaram P Singh
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:JGH Open
Subjects:
Online Access:https://doi.org/10.1002/jgh3.12152
_version_ 1818603544943525888
author Chitta R Khatua
Saroj K Sahu
Rakesh K Barik
Subhasis Pradhan
Subhendu Panigrahi
Debakanta Mishra
Shivaram P Singh
author_facet Chitta R Khatua
Saroj K Sahu
Rakesh K Barik
Subhasis Pradhan
Subhendu Panigrahi
Debakanta Mishra
Shivaram P Singh
author_sort Chitta R Khatua
collection DOAJ
description Background and Aim Acute kidney injury (AKI) commonly occurs in patients with chronic liver disease (CLD). As per the International Club of Ascites, AKI is classified into three stages; stage 1 has recently been divided into subgroups 1A and 1B. We performed a prospective study to validate the association between subgrouping and outcome. Methods This study was conducted using decompensated cirrhosis (DC) patients hospitalized in the Gastroenterology ward between August 2016 and May 2018. Demographic, clinical, and laboratory parameters were compared between AKI 1A and AKI 1B patients. The duration of hospitalization and outcome were compared. Results A total of 528 subjects were enrolled; 296 (56.1%) had AKI, and of them, 61.48% (n = 182) had stage 1, 20.95% (n = 62) had stage 2, and 17.57% (n = 52) had stage 3 AKI. Of the enrolled patients, 100 (54.94%) had early (AKI 1A) and 82 (45.06%) had late stage 1 AKI (AKI 1B). Patients with AKI 1B had higher total leucocyte count, total bilirubin, serum urea, serum creatinine (SCr), model for end‐stage liver disease (MELD), MELD‐Na+, and child‐turcotte‐pugh (CTP) score and decreased serum albumin than AKI 1A. The prevalence of hepatorenal syndrome (HRS), acute on chronic liver failure (ACLF) were higher in AKI 1B patients, and they had a prolonged hospital stay compared to AKI 1A patients. Furthermore, AKI 1B patients had significantly lower survival both at 28 days and 90 days. Conclusion Our study validates the subclassification of stage 1 AKI. Patients with AKI 1B more often progress to higher AKI stages with significantly lower 28‐day and 90‐day survival rates. Results justify subclassification and suggest the need for early intervention. The small increase in SCr should be viewed with caution in AKI stage 1A.
first_indexed 2024-12-16T13:24:52Z
format Article
id doaj.art-f76ea357f19a4b0f80471f8a14a06dc7
institution Directory Open Access Journal
issn 2397-9070
language English
last_indexed 2024-12-16T13:24:52Z
publishDate 2019-08-01
publisher Wiley
record_format Article
series JGH Open
spelling doaj.art-f76ea357f19a4b0f80471f8a14a06dc72022-12-21T22:30:15ZengWileyJGH Open2397-90702019-08-013429029410.1002/jgh3.12152Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver diseaseChitta R Khatua0Saroj K Sahu1Rakesh K Barik2Subhasis Pradhan3Subhendu Panigrahi4Debakanta Mishra5Shivaram P Singh6Department of Gastroenterology, Sriram Chandra Bhanja Medical College and Hospital, Cuttack 753007 Odisha IndiaDepartment of Gastroenterology, Sriram Chandra Bhanja Medical College and Hospital, Cuttack 753007 Odisha IndiaDepartment of Gastroenterology, Sriram Chandra Bhanja Medical College and Hospital, Cuttack 753007 Odisha IndiaDepartment of Gastroenterology, Sriram Chandra Bhanja Medical College and Hospital, Cuttack 753007 Odisha IndiaDepartment of Gastroenterology, Sriram Chandra Bhanja Medical College and Hospital, Cuttack 753007 Odisha IndiaDepartment of Gastroenterology, Sriram Chandra Bhanja Medical College and Hospital, Cuttack 753007 Odisha IndiaDepartment of Gastroenterology, Sriram Chandra Bhanja Medical College and Hospital, Cuttack 753007 Odisha IndiaBackground and Aim Acute kidney injury (AKI) commonly occurs in patients with chronic liver disease (CLD). As per the International Club of Ascites, AKI is classified into three stages; stage 1 has recently been divided into subgroups 1A and 1B. We performed a prospective study to validate the association between subgrouping and outcome. Methods This study was conducted using decompensated cirrhosis (DC) patients hospitalized in the Gastroenterology ward between August 2016 and May 2018. Demographic, clinical, and laboratory parameters were compared between AKI 1A and AKI 1B patients. The duration of hospitalization and outcome were compared. Results A total of 528 subjects were enrolled; 296 (56.1%) had AKI, and of them, 61.48% (n = 182) had stage 1, 20.95% (n = 62) had stage 2, and 17.57% (n = 52) had stage 3 AKI. Of the enrolled patients, 100 (54.94%) had early (AKI 1A) and 82 (45.06%) had late stage 1 AKI (AKI 1B). Patients with AKI 1B had higher total leucocyte count, total bilirubin, serum urea, serum creatinine (SCr), model for end‐stage liver disease (MELD), MELD‐Na+, and child‐turcotte‐pugh (CTP) score and decreased serum albumin than AKI 1A. The prevalence of hepatorenal syndrome (HRS), acute on chronic liver failure (ACLF) were higher in AKI 1B patients, and they had a prolonged hospital stay compared to AKI 1A patients. Furthermore, AKI 1B patients had significantly lower survival both at 28 days and 90 days. Conclusion Our study validates the subclassification of stage 1 AKI. Patients with AKI 1B more often progress to higher AKI stages with significantly lower 28‐day and 90‐day survival rates. Results justify subclassification and suggest the need for early intervention. The small increase in SCr should be viewed with caution in AKI stage 1A.https://doi.org/10.1002/jgh3.12152acute kidney injurychronic liver diseaseserum creatinine
spellingShingle Chitta R Khatua
Saroj K Sahu
Rakesh K Barik
Subhasis Pradhan
Subhendu Panigrahi
Debakanta Mishra
Shivaram P Singh
Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease
JGH Open
acute kidney injury
chronic liver disease
serum creatinine
title Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease
title_full Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease
title_fullStr Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease
title_full_unstemmed Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease
title_short Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease
title_sort validation of international club of ascites subclassification of stage 1 acute kidney injury in chronic liver disease
topic acute kidney injury
chronic liver disease
serum creatinine
url https://doi.org/10.1002/jgh3.12152
work_keys_str_mv AT chittarkhatua validationofinternationalclubofascitessubclassificationofstage1acutekidneyinjuryinchronicliverdisease
AT sarojksahu validationofinternationalclubofascitessubclassificationofstage1acutekidneyinjuryinchronicliverdisease
AT rakeshkbarik validationofinternationalclubofascitessubclassificationofstage1acutekidneyinjuryinchronicliverdisease
AT subhasispradhan validationofinternationalclubofascitessubclassificationofstage1acutekidneyinjuryinchronicliverdisease
AT subhendupanigrahi validationofinternationalclubofascitessubclassificationofstage1acutekidneyinjuryinchronicliverdisease
AT debakantamishra validationofinternationalclubofascitessubclassificationofstage1acutekidneyinjuryinchronicliverdisease
AT shivarampsingh validationofinternationalclubofascitessubclassificationofstage1acutekidneyinjuryinchronicliverdisease